SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Accession No. 0001193125-09-158140
Filing Date
2009-07-29
Accepted
2009-07-29 16:10:19
Documents
16
Period of Report
2009-07-29
Filing Date Changed
2009-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 491831
  Complete submission text file 0001193125-09-158140.txt   1531933

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT teva-20090630.xml EX-101.INS 240094
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20090630.xsd EX-101.SCH 8537
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20090630_cal.xml EX-101.CAL 35489
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20090630_lab.xml EX-101.LAB 85032
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20090630_pre.xml EX-101.PRE 64740
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 09970352
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1